Aperture Investors, LLC - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 48 filers reported holding FINCH THERAPEUTICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Aperture Investors, LLC ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q3 2022$322,000
-45.4%
192,794
-7.2%
0.05%
-45.9%
Q2 2022$590,000
-39.9%
207,729
+6.4%
0.10%
-22.8%
Q1 2022$982,000
-49.5%
195,2290.0%0.13%
-49.2%
Q4 2021$1,946,000
-35.5%
195,229
-15.8%
0.25%
-38.3%
Q3 2021$3,016,000
-32.8%
231,991
-27.3%
0.40%
-21.1%
Q2 2021$4,490,000
-39.9%
319,122
-32.0%
0.51%
-55.2%
Q1 2021$7,471,000469,5841.15%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q2 2022
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$653,7033.23%
Bleichroeder LP 810,416$318,4930.07%
Ikarian Capital, LLC 237,553$93,3590.02%
LAKE STREET ADVISORS GROUP, LLC 739,136$2910.02%
Baupost Group 2,019,008$7930.01%
Proficio Capital Partners LLC 110,559$43,4500.01%
MSD Partners, L.P. 153,397$60,2850.01%
Ballentine Partners, LLC 143,603$56,4360.00%
SVB WEALTH LLC 253,054$99,4500.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 18,783$7,3820.00%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders